annual report cancer research uk

Together we are beating cancer

• Cancer types
• Breast cancer
• Bowel cancer
• Lung cancer
• Prostate cancer
• Cancers in general
• Clinical trials
• Causes of cancer
• Coping with cancer
• Managing symptoms and side effects
• Mental health and cancer
• Money and travel
• Death and dying
• Cancer Chat forum
• Health Professionals
• Cancer Statistics
• Cancer Screening
• Learning and Support
• NICE suspected cancer referral guidelines
• Make a donation
• By cancer type
• Leave a legacy gift
• Donate in Memory
• Find an event
• Race for Life
• Charity runs
• Charity walks
• Search events
• Relay for Life
• Volunteer in our shops
• Help at an event
• Help us raise money
• Campaign for us
• Do your own fundraising
• Fundraising ideas
• Get a fundraising pack
• Return fundraising money
• Fundraise by cancer type
• Set up a Cancer Research UK Giving Page
• Find a shop or superstore
• Become a partner
• Cancer Research UK for Children & Young People
• Our Play Your Part campaign
• Brain tumours
• Skin cancer
• All cancer types
• By cancer topic
• New treatments
• Cancer biology
• Cancer drugs
• All cancer subjects
• All locations
• By Researcher
• Professor Duncan Baird
• Professor Fran Balkwill
• Professor Andrew Biankin
• See all researchers
• Our achievements timeline
• Our research strategy
• Involving animals in research
• Research opportunities
• For discovery researchers
• For clinical researchers
• For population researchers
• In drug discovery & development
• In early detection & diagnosis
• For students & postdocs
• Our funding schemes
• Career Development Fellowship
• Discovery Programme Awards
• Clinical Trial Award
• Biology to Prevention Award
• View all schemes and deadlines
• Applying for funding
• Start your application online
• How to make a successful applicant
• Funding committees
• Successful applicant case studies
• How we deliver research
• Our research infrastructure
• Events and conferences
• Our research partnerships
• Facts & figures about our funding
• Develop your research career
• Recently funded awards
• Manage your research grant
• Notify us of new publications
• Find a shop
• Volunteer in a shop
• Donate goods to a shop
• Our superstores
• Shop online
• Wedding favours
• Cancer Care
• Flower Shop
• Our eBay store
• Shoes and boots
• Bags and purses
• We beat cancer
• We fundraise
• We develop policy
• Our global role
• Our organisation
• Our strategy
• Our Trustees
• CEO and Executive Board
• How we spend your money
• Early careers
• Your development

Cancer News

• For Researchers
• For Supporters
• Press office
• Publications
• Update your contact preferences
• About cancer
• Get involved
• Our research
• Funding for researchers

The latest news, analysis and opinion from Cancer Research UK

• Science & Technology
• Health & Medicine
• Personal Stories
• Policy & Insight
• Charity News

2023/24 in review: Cancer Research UK powers progress in challenging economic climate

11 September 2024

Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today .   

“Every day, we see the impact of our vital work on those affected by cancer and their loved ones,” said Michelle Mitchell, chief executive of Cancer Research UK.  

“But none of this would’ve been possible without the generosity and commitment of our supporters, as well as the tireless work of our volunteers, partners and staff – so we want to say a huge thank you to them.”    

Driving impact for patients  

Cancer Research UK continues to deliver significant impact for cancer patients and their loved ones, driving progress to see major advances in the understanding, prevention, diagnosis and treatment of cancer from its world-class portfolio of research.  

Over the last financial year, two new drugs that Cancer Research UK helped to develop – Akeega™ for prostate and breast cancer and Truqap™ for HR-positive breast cancer – were approved and released for use.   

Cancer Research UK supported trials have also provided promising results. The INTERLACE trial brought a breakthrough in cervical cancer treatment, with results showing that giving people with cervical cancer a short course of chemotherapy before starting standard treatment cuts the risk of death or the disease returning by 35%.  

Meanwhile, new findings from the STAMPEDE trial have helped unlock new information about prostate cancer, providing clear evidence that adding the cancer drug Abiraterone to the current standard hormone therapy benefits people with prostate cancer at the early stages of the disease and once the cancer has already spread.   

To add to this, the charity’s flagship lung cancer study, TRACERx, made major advances in understanding how lung cancer evolves , spreads and resists treatment over time in seven new papers published in one month last year.   

With the launch of Cancer Research UK’s Smokefree UK campaign in July 2022, the charity, along with its partners, has been continuing to call for government action on tobacco. So, the charity was pleased when plans were announced to progressively raise the age of sale of tobacco products to create the first smokefree generation – a bill which is now being supported by the UK Government.   

Additionally, the charity continues to reach people with trusted expert information. Last year, the About Cancer area of Cancer Research UK’s website was visited 52 million times by more than 24 million people around the world.   

Supporting cutting-edge research  

Cancer Research UK is the world’s largest charitable funder of cancer research, spending £399m on research in the financial year of 2023/24. This includes £93m on research relevant to all types of cancer and £84m on basic research to understand the fundamental biology of cancer.   

The charity is also the biggest charitable funder of research into children’s and young people’s cancers in the UK, spending £19.9m on research specific to cancers that affect 0-24-year-olds.   

Key figures from the Annual Report and Accounts include:  

• Income was £684m, which is the second highest over the past five years, following an exceptional year in 2022/23 when the charity received a particularly generous £44m legacy gift.  
• The charity continues to widen its sources of income via activities such as social media challenges, and in February 2024 launched More Research, Less Cancer – the largest-ever philanthropic campaign for a UK based charity with the aim of raising £400m.  

A tough economic climate  

These successes have been achieved against the backdrop of a tough external environment, which includes the continued cost-of-living crisis and inflationary pressures affecting the charity’s costs, ability to raise money and eroding the value of each pound spent on research.   

Cancer Research UK is facing these challenges head on, including making investments in digital transformation that will lead to future income growth and keeping a resolute focus on increasing impact and effectiveness.   

Despite these challenges, the charity continues to deliver well on its 10-year strategy , with continued good progress and impressive impact across the five focus areas – discover, translate, engage, partner and sustain. It also remains on track to deliver on its aim to invest £1.5bn on research from 2021/22 – 2025/26.    

Continuing to push for progress  

While the charity is pleased with its overall financial performance and progress, it remains deeply concerned about the situation facing cancer patients across the UK.   

Prior to the general election this year, Cancer Research UK published Longer, better lives: A manifesto for cancer research and care , which set out how to improve cancer outcomes.   

“Despite more people being treated than before – and NHS staff working tirelessly – many people are waiting longer for tests and treatments than ever before across the UK,” said Mitchell.   

“This is unacceptable and we’re calling on the UK Government to publish a 10-year cancer strategy for England – this will be essential in ensuring patients get the care they need and deserve.”    

Scotland and Northern Ireland have recognised the need for long-term cancer strategies, with both nations having 10-year cancer specific strategies. Implementing them in full is challenging, so full funding and clear focus is needed to ensure better cancer outcomes. Wales has a 3-year cancer specific improvement plan and we hope to see the Welsh Government introduce an even longer-term cancer strategy post 2026. This leaves England as an outlier.

The challenges in cancer care need addressing, but looking ahead, Cancer Research UK remains optimistic that new discoveries and treatments will continue to improve survival rates.  

“What gives me, and all of us, hope, is the opportunity that lies before us,” said Mitchell.   

“Advances in data, AI and genomics, have created a unique opportunity to transform cancer prevention, diagnosis and treatment in the next 10 years.   

“Understanding of cancer is improving every day and there is excitement among the research community to utilise new tools to go further and faster, ultimately helping to improve outcomes for people affected by cancer.   

“By mobilising our researchers, clinicians, supporters, staff, volunteers and partners, we will continue powering progress for patients in the years to come.” 

Tell us what you think

Leave a reply cancel reply.

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Read our comment policy .

Highlighted content

12 ways we’ve influenced progress in lung cancer , the story of genomics - and our plan for its next chapter, can we use ai to help our immune systems fight cancer, more than a sweet treat: 'lollipops' could help diagnose mouth cancer, when lung cancer killed my dad, the first thing i did was light up a cigarette, “it must be more than just bad luck – it must be genetic”: three women with brca gene mutations share their experiences, more like this, stand up to cancer: how the entertainment industry is helping us fund life-saving research, su2c gives £7.5m more to improve treatments for children’s and young people’s cancers, the uk immigration system is holding us back in the fight to beat cancer, related topics.

• Cancer Research UK service
• Cancer Research UK-funded research

Accounts and annual returns CANCER RESEARCH UK

(Charity users only)

Tell us whether you accept cookies

We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.

We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.

Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service? Open in new window

Together we are beating cancer

About cancer

Cancer types

• Breast cancer
• Bowel cancer
• Lung cancer
• Prostate cancer

Cancers in general

• Clinical trials

Causes of cancer

Coping with cancer

• Managing symptoms and side effects
• Mental health and cancer
• Money and travel
• Death and dying
• Cancer Chat forum

Health Professionals

• Cancer Statistics
• Cancer Screening
• Learning and Support
• NICE suspected cancer referral guidelines

Get involved

• Make a donation

By cancer type

• Leave a legacy gift
• Donate in Memory

Find an event

• Race for Life
• Charity runs
• Charity walks
• Search events
• Relay For Life
• Volunteer in our shops
• Help at an event
• Help us raise money
• Campaign for us

Do your own fundraising

• Fundraising ideas
• Get a fundraising pack
• Return fundraising money
• Fundraise by cancer type
• Set up a Cancer Research UK Giving Page
• Find a shop or superstore
• Become a partner
• Cancer Research UK for Children & Young People
• Our We Are campaign

Our research

• Brain tumours
• Skin cancer
• All cancer types

By cancer topic

• New treatments
• Cancer biology
• Cancer drugs
• All cancer subjects
• All locations
• Our achievements timeline
• Our research strategy
• Involving animals in research

Funding for researchers

Research opportunities

• For discovery researchers
• For clinical researchers
• For population researchers
• In drug discovery & development
• In early detection & diagnosis
• For students & postdocs

Our funding schemes

• Career Development Fellowship
• Discovery Programme Awards
• Clinical Trial Award
• Biology to Prevention Award
• View all schemes and deadlines

Applying for funding

• Start your application online
• How to make a successful application
• Funding committees
• Successful applicant case studies

How we deliver research

• Our research infrastructure
• Events and conferences
• Our research partnerships
• Facts & figures about our funding
• Patient involvement toolkit for researchers
• Develop your research career
• Recently funded awards
• Manage your research grant
• Notify us of new publications

Find a shop

• Volunteer in a shop
• Donate goods to a shop
• Our superstores

Shop online

• Wedding favours
• Cancer Care
• Flower Shop

Our eBay store

• Shoes and boots
• Bags and purses
• We beat cancer
• We fundraise
• We develop policy
• Our global role

Our organisation

• Our strategy

Our Trustees

• CEO and Executive Board
• How we spend your money
• Early careers

Cancer news

• Cancer News
• For Researchers
• For Supporters
• Press office
• Publications
• Update your contact preferences

ABOUT CANCER

GET INVOLVED

NEWS & RESOURCES

FUNDING & RESEARCH

You are here

A number of bodies work together to ensure that we make the best use of the funds we receive and continue to carry out world-class research.

Get in touch

Cancer Research UK

2 Redman Place ​London E20 1JQ

020 7242 0200

More ways to contact us

T he Council of trustees sets the Charity’s strategic direction, monitors the delivery of the Charity’s objectives, uphold its values and governance and advises the Chief Executive.

Our Code of Conduct

Chief executive and executive board.

Our Chief Executive and Executive Board work together to ensure that the charity continues to carry out world class research.

Meet our Chief Executive and Executive Board

Our Code of Ethics

Our Code of Ethics serves as a guide for how to approach making difficult decisions and sets out how we’re all expected to conduct ourselves in our work for Cancer Research UK.  

Our strategy to beat cancer

For the past 120 years, we’ve been making discoveries that have saved countless lives. But we have so much more to do. Our strategy sets out how we'll accelerate progress towards a better future.

Our Scientific Executive Board

The role of the Scientific Executive Board is to develop and implement Cancer Research UK's scientific strategy. 

Our Members

Cancer Research UK’s constitution provides for the appointment of 100 Members of the charity which are similar to shareholders of a company.

Annual Report and accounts 2022/23

Our Annual Report and accounts 2022/23 reviews our performance for the year, our income and expenditure, the progress we're making against our objectives and our aims for the future.

Responsible organisation at Cancer Research UK

We want to maximise the positive impact our life-saving research has on people and the planet, while minimising the negative impact.

Equality, diversity and inclusion (EDI)

As the UK’s largest charity, we recognise the positive role we can play in developing and embedding EDI best practice across all our business operations, including our public engagement and outreach work.

More in this section